http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104529919-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16
filingDate 2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104529919-B
titleOfInvention Cocrystal of 2-(5-bromo-4-(4-cyclopropylnaphthalene-1-yl)-4H-1,2,4-triazole-3-ylthio)acetic acid and preparation method thereof
abstract The present invention relates to two cocrystal forms of compound 2-(5-bromo-4-(4-cyclopropylnaphthalene-1-yl)-4H-1,2,4-triazole-3-ylthio)acetic acid , involving co-crystals of 2-(5-bromo-4-(4-cyclopropylnaphthalene-1-yl)-4H-1,2,4-triazole-3-ylthio)acetic acid-proline, respectively Cocrystal form of Form A and 2-(5-bromo-4-(4-cyclopropylnaphthalene-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid-glycolic acid b. The drug co-crystal of the invention has stable physical and chemical properties, can be stored stably for a long time, has a simple preparation method and good repeatability, and has extremely strong practical application value.
priorityDate 2013-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103298796-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67325663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420859410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID116085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457778434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145742
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53465279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14668693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420199739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486837
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID365398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451920020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587

Total number of triples: 38.